These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Recurrent life-threatening acidosis induced by acetazolamide in a patient with diabetic type IV renal tubular acidosis. Elinav E; Ackerman Z; Gottehrer NP; Heyman SN Ann Emerg Med; 2002 Aug; 40(2):259-60. PubMed ID: 12140510 [No Abstract] [Full Text] [Related]
25. Metabolic acidosis and hyperventilation induced by acetazolamide in patients with central nervous system pathology. Venkatesha SL; Umamaheswara Rao GS Anesthesiology; 2000 Dec; 93(6):1546-8. PubMed ID: 11149457 [No Abstract] [Full Text] [Related]
26. [Carbonic anhydrase inhibitors and calcium phosphate stones]. Barbey F; Nseir G; Ferrier C; Burnier M; Daudon M Nephrologie; 2004; 25(5):169-72. PubMed ID: 15455790 [TBL] [Abstract][Full Text] [Related]
27. Transient renal tubular acidosis in a neonate following transplacental acetazolamide. Ozawa H; Azuma E; Shindo K; Higashigawa M; Mukouhara R; Komada Y Eur J Pediatr; 2001 May; 160(5):321-2. PubMed ID: 11388607 [TBL] [Abstract][Full Text] [Related]
28. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors. Wisch N; Fischbein FI; Siegel R; Glass JL; Leopold I Am J Ophthalmol; 1973 Jan; 75(1):130-2. PubMed ID: 4684255 [No Abstract] [Full Text] [Related]
29. Acetazolamide and Cardiac Failure. Cimolai N Clin Drug Investig; 2018 Jul; 38(7):649-650. PubMed ID: 29736885 [No Abstract] [Full Text] [Related]
30. Response to "Acetazolamide and Cardiac Failure". Imiela T; Budaj A Clin Drug Investig; 2018 Jul; 38(7):651. PubMed ID: 29736884 [No Abstract] [Full Text] [Related]
31. Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Schwenk MH; St Peter WL; Meese MG; Singhal PC Pharmacotherapy; 1995; 15(4):522-7. PubMed ID: 7479208 [TBL] [Abstract][Full Text] [Related]
32. Acetazolamide and prevention of acute mountain sickness. Prescrire Int; 2014 Nov; 23(154):273. PubMed ID: 25954800 [TBL] [Abstract][Full Text] [Related]
33. Toxicity of combined therapy with carbonic anhydrase inhibitors and aspirin. Anderson CJ; Kaufman PL; Sturm RJ Am J Ophthalmol; 1978 Oct; 86(4):516-9. PubMed ID: 707596 [TBL] [Abstract][Full Text] [Related]
34. [Tachyphylactic Effects after Long-term Use of Systemic Acetazolamide]. Engesser KM; Prètot D; Schlote T; Della Volpe Waizel M Klin Monbl Augenheilkd; 2024 Apr; 241(4):559-561. PubMed ID: 38387484 [No Abstract] [Full Text] [Related]
35. Acetazolamide Use in an Ultra-Runner: A Complicated Treatment Consideration for AMS. Biondich AS; Joslin JD Wilderness Environ Med; 2016 Mar; 27(1):179-80. PubMed ID: 26520404 [No Abstract] [Full Text] [Related]
36. Inhibition of carbonic anhydrase in the lens does not induce myopia in cynomolgus monkeys. Wistrand PJ Ups J Med Sci; 2001; 106(2):117-21. PubMed ID: 11888067 [TBL] [Abstract][Full Text] [Related]
37. Acetazolamide treatment of CME in patients with uveitis. Rho D Ophthalmology; 1996 Nov; 103(11):1717; author reply 1717-8. PubMed ID: 8942860 [No Abstract] [Full Text] [Related]
38. Acetazolamide treatment of CME in patients with uveitis. Flach A Ophthalmology; 1996 Nov; 103(11):1715-6; author reply 1716-7. PubMed ID: 8942859 [No Abstract] [Full Text] [Related]